BLI
$47.06
Berkeley Lights
$1.26
2.75%
Earnings Details
1st Quarter March 2021
Tuesday, May 11, 2021 6:00:00 AM
Tweet Share Watch
Summary

Berkeley Lights Reaffirms

Berkeley Lights (BLI) reported a 1st Quarter March 2021 loss of $0.24 per share on revenue of $18.6 million. The consensus estimate was a loss of $0.23 per share on revenue of $16.6 million.

The company said it continues to expect 2021 revenue of $90.0 million to $100.0 million. The current consensus revenue estimate is $93.99 million for the year ending December 31, 2021.

erkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect chips and reagent kits, advanced automation systems, and application software.

Results
Reported Earnings
($0.24)
Earnings Whisper
-
Consensus Estimate
($0.23)
Reported Revenue
$18.6 Mil
Revenue Estimate
$16.6 Mil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

Berkeley Lights Reports First Quarter 2021 Financial Results

EMERYVILLE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended March 31, 2021.

Recent Highlights

  • Total revenue of $18.6 million for the first quarter of 2021, representing 35% growth year over year
  • Grew the installed base to 85 platforms during the first quarter of 2021, with eight new direct placements and two existing platforms added upon the successful completion of a joint development and partnership program
  • Announced the launch of Opto Assure, the first of a series of assays that will provide yield and product quality data at an earlier stage in cell development
  • ?Appointed Greg Lucier as Chairperson and John Chiminski as an Independent Director to its Board of Directors

?“We started the year with strong platform placements, continued to expand opportunities in our core business and grew our total addressable market,” said Berkeley Lights Chief Executive Officer Eric Hobbs, Ph.D. “As we look ahead in 2021, I continue to be excited about the opportunities in front of us and I am confident that we are well positioned to execute our strategy to transform the market for cell-based products this year and beyond.”

First Quarter 2021 Financial Results

 Three Months Ended March 31,
(in thousands, except per share data)20212020
 (unaudited)(unaudited)
Revenue        $18,628  $13,778  
Gross profit        12,451  9,979  
Gross margin %        67 %72 %
Operating expenses        27,600  18,207  
Loss from operations        (15,149) (8,228) 
Net loss and net comprehensive loss        (15,435) (8,425) 
Net loss attributable to common stockholders per share, basic and diluted        (0.24) (3.02) 
Total stock-based compensation        4,494  1,179  

2021 Outlook

Berkeley Lights continues to expect full year 2021 revenue to be in the range of $90 million to $100 million, representing 40% to 56% growth over the full year of 2020.

Webcast and Conference Call Information

Berkeley Lights will host a conference call to discuss the first quarter 2021 financial results before market open on Tuesday, May 11, 2021 at 5:30 a.m. Pacific Time/8:30 a.m. Eastern Time. A webcast of the conference call can be accessed at http://investors.berkeleylights.com. The webcast will be archived and available for replay for at least 90 days after the event.

About Berkeley Lights

Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.         

Berkeley Lights’ Beacon and Lightning systems and Culture Station instrument are: FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Forward Looking Statements

This press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize and achieve market acceptance of our current and planned products and services, our research and development efforts, and other matters regarding our business strategies, use of capital, results of operations and financial position, and plans and objectives for future operations.

In some cases, you can identify forward-looking statements by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties and other factors are described under "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in the documents we file with the Securities and Exchange Commission from time to time. We caution you that forward-looking statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. As a result, the forward-looking statements may not prove to be accurate. The forward-looking statements in this press release represent our views as of the date hereof. We undertake no obligation to update any forward-looking statements for any reason, except as required by law.

Press Contact
berkeleylights@bulleitgroup.com

Investor Contact
ir@berkeleylights.com


Berkeley Lights, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
(In thousands, except share and per share data)

 Three months ended March 31, 
 2021 2020 
     
Revenue:    
Product revenue$13,533  $10,683  
Service revenue5,095  3,095  
Total revenue18,628  13,778  
Cost of sales:    
Product cost of sales3,703  2,620  
Service cost of sales2,474  1,179  
Total cost of sales6,177  3,799  
Gross profit12,451  9,979  
Operating expenses:    
Research and development13,027  10,976  
General and administrative8,967  3,997  
Sales and marketing5,606  3,234  
Total operating expenses27,600  18,207  
Loss from operations(15,149) (8,228) 
Other income (expense):    
Interest expense(354) (357) 
Interest income66  151  
Other income (expense), net19  25  
Loss before income taxes(15,418) (8,409) 
Provision for income taxes17  16  
Net loss and net comprehensive loss$(15,435) $(8,425) 
     
Net loss attributable to common stockholders per share, basic and diluted$(0.24) $(3.02) 
Weighted-average shares used in calculating net loss per share, basic and diluted65,259,398  3,047,967  


Berkeley Lights, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)

AssetsMarch 31,
2021
 December 31,
2020
 (unaudited)  
Current assets:   
Cash and cash equivalents$230,165  $233,408 
Trade accounts receivable16,432  12,939 
Inventory10,941  11,047 
Prepaid expenses and other current assets8,240  8,175 
Total current assets265,778  265,569 
Restricted cash270  270 
Property and equipment, net17,152  14,544 
Operating lease right-of-use assets16,223  16,718 
Other assets3,528  2,557 
Total assets$302,951  $299,658 
Liabilities and Stockholders’ Equity   
Current liabilities:   
Trade accounts payable$6,934  $3,491 
Accrued expenses and other current liabilities8,153  8,401 
Current portion of notes payable16,592  11,594 
Deferred revenue7,929  5,482 
Total current liabilities39,608  28,968 
Notes payable, net of current portion3,320  8,301 
Deferred revenue, net of current portion2,301  1,709 
Lease liability, long-term15,356  15,899 
Total liabilities60,585  54,877 
Stockholders’ equity:   
Convertible preferred stock   
Common stock4  3 
Additional paid-in capital449,681  436,662 
Accumulated deficit(207,319) (191,884)
Total stockholders’ equity242,366  244,781 
   Total liabilities and stockholders’ equity$302,951  $299,658 

Primary Logo

Source: Berkeley Lights, Inc